LOS ANGELES CAPITAL MANAGEMENT LLC

Position in NTRA — Natera, Inc.

CIK 1177206 LOS ANGELES, CA

Position in NTRA

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$13,042,086

+$12,925,092 QoQ

Shares Held

48,046

+8113.0% QoQ

Ownership

0.033%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#180

of 844 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 81% Shared 0% None 19%

Healthcare · as of Jun 30, 2026

LOS ANGELES CAPITAL MANAGEMENT LLC holds $124,186,888 across 28 Diagnostics & Research names. NTRA ranks #3 (10.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	A	Agilent Technologies, Inc.	477,841	$63,471,620
2	IQV	Iqvia Holdings Inc.	131,127	$25,336,358
3	NTRA	Natera, Inc. This page	48,046	$13,042,086
4	IDXX	Idexx Laboratories Inc /De	17,602	$9,266,396
5	MEDP	Medpace Holdings, Inc.	10,200	$5,401,818
6	VCYT	Veracyte, Inc.	69,585	$4,086,727
7	TMO	Thermo Fisher Scientific Inc.	1,631	$817,718
8	GH	Guardant Health, Inc.	3,578	$536,807

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$13,042,086	48,046	+8113.0%	Shares	Sole	2026-08-13
2026-03-31	$116,994	585	-92.1%	Shares	Sole	2026-05-08
2025-12-31	$1,703,284	7,435	-0.5%	Shares	Sole	2026-02-11
2025-09-30	$1,203,250	7,475	-40.2%	Shares	Sole	2025-10-20
2025-03-31	$1,767,342	12,498	+457.9%	Shares	Sole	2025-05-05
2021-12-31	$209,193	2,240	-5.4%	Shares	Sole	2022-02-03
2021-09-30	$263,778	2,367	-86.2%	Shares	Sole	2021-11-08
2021-03-31	$1,740,294	17,139	-50.2%	Shares	Sole	2021-05-05
2020-12-31	$3,426,573	34,431	-4.1%	Shares	Sole	2021-03-10
2020-09-30	$2,593,127	35,896	+44.6%	Shares	Sole	2020-11-02
2020-06-30	$1,237,325	24,816	+15.0%	Shares	Sole	2020-08-05
2020-03-31	$644,259	21,576	—	Shares	Sole	2020-05-04
No filing history on record for this holder in this stock.